Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Global Therapeutic Apheresis Market to nearly double to $8.94B by 2035 with 7.9% CAGR driven by chronic disease demand.
TER
$325.38
-$16.74 -4.89%

Global Therapeutic Apheresis Market to nearly double to $8.94B by 2035 with 7.9% CAGR driven by chronic disease demand.

Market News
25 Jun 2026
Healthcare Foresights
View Source
Bullish
pluang ai news

The global therapeutic apheresis market, valued at $3.84 billion in 2025, is projected to grow to $8.94 billion by 2035 at a 7.9% CAGR. Growth is fueled by rising chronic and autoimmune diseases, advances in automated apheresis technology, and expanding healthcare infrastructure, especially in North America and Asia Pacific. Key players include Terumo BCT, Fresenius Kabi, and Haemonetics. The market covers devices, consumables, and procedures for treating neurological, hematological, renal, cardiovascular, and autoimmune disorders. Increasing awareness, reimbursement improvements, and government initiatives also support expansion.

More News (TER)

Teradyne rated a buy with 43% upside on AI-driven earnings growth and chip testing demand.

Teradyne rated a buy with 43% upside on AI-driven earnings growth and chip testing demand.

Analyst The Curious Analyst rates Teradyne as a buy with a $484 price target, suggesting a 43% upside from its current $339 price. The company’s earnings are expected to grow due to AI advancements, increased chip complexity, and expanded testing nee...

Analyst Insights
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App